Effect of HDAC-6 on PD cell induced by lactacystin  by Xing, Li-Fei et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2015; 8(10): 855–859 855Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2015.09.013*Corresponding author: Su-Yue Pan, Department of Neurology, Nanfang Hospital, Southern Medical University, Guangz
Tel: +86 021 62786261
E-mail: Pansuyue82@qq.com
Peer review under responsibility of Hainan Medical College.
Foundation Project: It is supported by Natural Science Foundation of Guangdong Province: (gd28182334).
1995-7645/Copyright © 2015 Hainan Medical College. Production and hosting by Elsevier (Singapore) Pte Ltd. This is an
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Effect of HDAC-6 on PD cell induced by lactacystinLi-Fei Xing1,2, Dong-Tao Wang3, Yu Yang4, Su-Yue Pan5*1Nanfang Hospital, Southern Medical University, China
2Department of Neurology, Inner Mongolia North Heavy Industries Group Corp. Ltd Hospital (The Third Afﬁliated Hospital of Baotou Medical
College), China
3Department of Thoracic Surgery, The Central Hospital, Baotou, Inner Mongolia, China
4Department of Endocrinology, Inner Mongolia North Heavy Industries Group Corp. Ltd Hospital (The Third Afﬁliated Hospital of Baotou Medical
College), China
5Department of Neurology, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaARTICLE INFO
Article history:
Received 15 Jul 2015
Received in revised form 20 Aug
2015
Accepted 15 Sep 2015
Available online 25 Sep 2015
Keywords:
HDAC-6
Lactacystin
PD cell modelABSTRACT
Objective: To explore the effects of histone deacetylase 6(HDAC-6) on the PD cell
model induced by proteasome inhibitor lactacystin.
Methods: Human neuroblastoma SK-N-SH cells were cultured. The wild type
pcDNA3.1-alpha-synuclein eukaryotic expression plasmid was transferred into the cells
which then were divided into control group, group L, group T and group T+L. The cells
of group L were added with 5 mmol/L lactacystin dissolved indimethylsulfoxide (DMSO)
to induce PD cell model with abnormal protein aggregation, the cells of control group
were treated with 5 mmol/L DMSO, the cells of group T were treated with 5 mmol/L
selective HDAC-6 inhibitor tubacin dissolved in DMSO, and the cells of group T+L were
treated with 5 mmol/L lactacystin and 10 mmol/L tubacin dissolved in DMSO. The
expression levels of alpha-synuclein oligomers, HSP-27 and HSP-70 were detected by
Western blot and the cell survival rate of all the groups was detected by MTT colorimetric
assay, and compared 24 h after the cells were treated.
Results: The expression levels of alpha-synuclein oligomers, HSP-27 and HSP-70 of the
cells of group L were signiﬁcantly higher than the control group, and the cell survival rate
was signiﬁcantly lower (P < 0.05); the expression level of alpha-synuclein oligomers of
the cells of group T+L was signiﬁcantly higher than group L, but the expression level of
HSP-27 and HSP-70 were signiﬁcantly lower, and so as the cell survival rate (P < 0.05);
the differences of the expression level of alpha-synuclein oligomers, HSP-27 and HSP-70
and the cell survival rate of the cells of group T and the control group were not statis-
tically signiﬁcant (P > 0.05).
Conclusions: The expression level of alpha-synuclein oligomers can be improved and
the cell survival rate can be reduced by the PD cell model induced by lactacystin and
treated with selective HDAC-6 inhibitor tubacin, which means that alpha-synuclein
oligomers of the PD cell model induced by lactacystin can be inhibited and the cell
survival rate can be improved by HDAC-6, and the mechanism may be related to the
increased of HSP-27 and HSP-70.hou, China.
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As a kind of protease, histone deacetylase 6 (HDAC-6) plays
a very important role in the gene expression regulation and
structure modiﬁcation of chromosome [1]. Studies have shown
that the histone acetylation is one of the necessary conditions
for the dissociation of DNA and histone octamer, and can
make nucleosome structure relaxed to enable various
transcription factors to speciﬁcally bind with DMA binding
sites, resulting in the activation of transcription of genes in the
nucleus [2]. In the nucleus, histone acetylation and histone
deacetylation reach equilibrium state under the common
control of histone acetyltransferase (HAT) and histone
deacetylase (HDAC). On the one hand, HAT can transfer the
acetyl of acetyl coenzyme A to the speciﬁc lysine residue at
the amino terminus of histone. On the other hand, HDAC-6
can make histone deacetylated and closely combine with nega-
tively charged DNA to make chromatin dense and curly, thereby
inhibiting the transcription of genes [3].
Alpha-synuclein is a soluble protein expressing in the pre-
synaptic area and around the nucleus of the central nervous
system. Its unique NAC domain constitutes the main component
of Lewy body, and it is closely related to the pathogenesis of
Parkinson's disease and related dysfunctions [4]. When the gene
point of alpha-synuclein mutates or ampliﬁes, it can form a beta
lamellar like structure and rapidly gather into oligomers. Then it
can resist the degradation of ubiquitin proteasome, induce
mitochondrial dysfunction and increase free dopamine in the
cytoplasm, ultimately leading to the destruction of dopaminergic
neurons [5]. Studies have shown that HDAC-6 can reduce the
formation of alpha-synuclein oligomers and promotes their
degradation through a variety of ways, so as to relieve the
symptoms of Parkinson patients [6]. In this study, the expression
level of alpha-synuclein oligomers, HSP-27 and HSP-70 were
observed and compared after the function of HDAC-6 were
inhibited in the PD cell model induced by lactacystin, in order to
explore the effects and mechanism of HDAC-6 on the PD cell
model induced by lactacystin.
2. Materials and methods
2.1. Materials
Human neuroblastoma SK-N-SH cells, DMEM high glucose
culture medium, 10% bovine serum, 0.05% trypsin, alpha-
synuclein recombinant plasmid DNA, proteasome inhibitor
lactacystin, selective HDAC-6 inhibitor tubacin, dimethylsulf-
oxide (DMSO), Thiazolyl blue tetrazolium bromide (MTT)
(Shanghai Research Domain Biological Technology Co., Ltd.),
G418 culture medium (Suzhou Tianke Trading Co., Ltd.), 5%
CO2 incubator (center lab of Hong Kong University Shenzhen
Hospital) and Lipofectamine 2000 (Suzhou Biotsith Bioscience
Co., Ltd.).
2.2. Methods
2.2.1. Cell culture
The SK-N-SH cells were cultured in the DMEM high glucose
culture medium containing 10% bovine serum and placed in 5%
CO2 incubator with a temperature of 37 C. The liquid waschanged 1–2 times per week. When being subcultured to ﬁfth
generation, 0.05% trypsin was used for digestion.
2.2.2. Transfection
The extracted alpha-synuclein recombinant plasmid DNA
was transferred into SK-N-SH cells after subculture with Lip-
ofectamine 2000. After cells were cloned into groups, they were
cultured in the whole plate containing 750 mg/mL G418 culture
medium.
2.2.3. Grouping
The transfected cells were randomly divided into control
group, group L, group T and group T+L according to the
random number table method. The cells of group L were added
with 5 mmol/L lactacystin dissolved in DMSO to induce PD cell
model with abnormal protein aggregation, the cells of control
group were treated with 5 mmol/L DMSO, the cells of group T
were treated with 5 mmol/L tubacin dissolved in DMSO, and the
cells of group T+L were induced by 5 mmol/L lactacystin dis-
solved in DMSO and treated with 10 mmol/L tubacin.
2.2.4. Detection indexes
The expression level of alpha-synuclein oligomers, HSP-27
and HSP-70 detected by Western blot [7] and the cell survival
rate of all the groups detected by MTT colorimetric assay [8]
were compared 24 h after the cells were treated.
2.3. Statistical methods
The data in the study were inputted into SPSS17.0 for data
analysis. Measure data were analyzed with homogeneity of
variance test and one-way analysis of variance. The data be-
tween every two groups were compared with SNK method. A P
value < 0.05 was considered statistically signiﬁcant difference.
3. Results
3.1. Comparison of expression level of alpha-synuclein
oligomers
The expression level of alpha-synuclein oligomers of the
cells of group L was signiﬁcantly higher than the control group
of DMSO, and the expression level of alpha-synuclein oligomers
of the cells of group T+L was signiﬁcantly higher than group L
after inhibiting HDAC-6 (P < 0.05); the difference of the
expression level of alpha-synuclein oligomers of the cells of
group T after treating and the control group of DMSO was not
statistically signiﬁcant (P > 0.05) (Figures 1 and 2).
3.2. Comparison of expression level of HSP-27 and
HSP-70
The expression level of HSP-27 and HSP-70 of the cells of
group L were signiﬁcantly higher than the control group, but the
expression level of HSP-27 and HSP-70 of the cells of group
T+L were signiﬁcantly lower than group L after inhibiting
HDAC-6 (P < 0.05); the differences of the expression level of
HSP-27 and HSP-70 of the cells of group T after treating and the
control group of DMSO were not statistically signiﬁcant
(P > 0.05) (Figures 3 and 4).
Figure 2. Relative expression of alpha-synuclein oligomers.
Figure 5. Comparison of cell survival rate in each group.
Figure 1. Expression map of alpha-synuclein oligomers.
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The cell survival rate of group L was signiﬁcantly lower than
the control group, and the cell survival rate of group T+L was
signiﬁcantly lower than group L after inhibiting HDAC-6
(P < 0.05); the difference of the cell survival rate of the cells
of group T after treating and the control group was not statis-
tically signiﬁcant (P > 0.05) (Figure 5).Figure 4. Relative expression of HSP-27 and HSP-70.
Figure 3. Expression map of HSP-27 and HSP-70 oligomers.4. Discussion
Parkinson's disease, also known as idiopathic Parkinson's
disease (PD) or Parkinson for short, referred to as paralysis
agitans or shaking palsy, is a neurodegenerative disease common
in middle aged and elderly people, and the most common
extrapyramidal disease in middle aged and elderly people [9].
According to incomplete statistics, the morbidity rate of
elderly people over 60 years old reaches 1000 per 100
thousand, and with the increase of age, the incidence of men
is slightly more than women [10]. The main clinical
manifestations of PD are static tremor, hypermyotonia,
postural instability, movement delay and reduction and so on
[11]. The cause of PD is still not very clear. It has been found
that some central nervous system degeneration diseases can
accompanied by the symptoms of PD, which mainly include
degeneration in different parts of the central nervous system
and other clinical features, such as striatonigral degeneration,
SDS syndrome, progressive supranuclear paralysis,
olivopontocerebellar atrophy and so on [12]. There are some
diseases or factors that can produce clinical symptoms similar
to PD, such as infection, poison (MPTP, carbon monoxide,
manganese, etc.), vascular cause (multiple cerebral infarction),
drugs (dopamine receptor blocking drugs, etc.), brain trauma
and other causes, so they are all called Parkinson's syndrome
or Parkinsonism clinically [13].
The most notable pathological changes of PD are degenera-
tion and loss of neurons containing pigment, degeneration of DA
neurons in the compact part of substantia nigra and so on [14].
Under microscope, melanin of the substantia negra cells
disappears, or melanin granules are scattered in the tissues and
macrophages, nerve cells decrease and neuroglia proliferates in
different extent. It has been reported that the substantia nigra
cells of normal people decrease with age. At the age of 80,
they decrease from original 425 thousand to 200 thousand,
and the substantia nigra cells of PD patients are less than 100
thousand. DA neurons can lose more than 50% when
symptoms occur. Locus coeruleus, raphe nuclei, dorsal nucleus
of vagus nerve, globuspallidus, putamen, caudate nucleus,
subthalamic nucleus and so on also show mild changes. An
important pathological feature of the disease is the appearance
of eosinophilic inclusion Lewy body in the cytoplasm of
residual neurons [15–18]. Lewy body is a kind of hyaloid mass
composed of protein in the cytoplasm with a dense core in the
centre and ﬁlamentous halos in the surrounding. Many Lewy
bodies of different sizes sometimes can be seen in one of
about 10% of the remaining cells. It is obvious in the
substantia nigra and common in the globuspallidus, corpus
striatum, locus coeruleus, etc. And it has been proved that
alpha-synuclein and ubiquitin are the important components of
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equilibrium in the normal, misfolding and oligomerization of
alpha-synuclein, and when this equilibrium is broken, ﬁbrils
rapidly gather into large molecules, insoluble ﬁne ﬁbers; Alpha-
synuclein may shows many kinds of forms under the inﬂuence
of different factors, which include stretch form, ball form before
dissolution, alpha-helix form (membrane binding), beta lamellar
like form, dimer form, oligomer form, insoluble amorphous
form and ﬁber form [20]; The point mutation of alpha-synuclein
can lead to structural change, increase of intracellular content,
accumulation of large amounts of protein molecules, truncated
sequence, concentration of intracellular anions and salts (change
of pH value), neurotoxic molecules (heavy metals, organic sol-
vents, carbon monoxide, MPTP, pesticides and herbicides),
post-translational modiﬁcation (oxidation, phosphorylation and
nitration) and so on, which can promote the alpha-synuclein to
gather to form insoluble ﬁbers [21]; The oligomer form of alpha-
synuclein, which is considered the most cytotoxic currently, can
not only resist the degradation of ubiquitin protease, but also
induce mitochondrial dysfunction and increase the free dopa-
mine in the cytoplasm, ultimately leading to the destruction of
dopaminergic neurons [22]. And HDAC-6 can prevent the inci-
dence of PD patients by reducing the formation of alpha-
synuclein oligomers or promote their degradation [23].
Therefore, the effects and mechanism of HDAC-6 can be
explored through the expression level of alpha-synuclein in the
PD cell model induced by lactacystin.
In the study, the expression level of alpha-synuclein oligo-
mers detected by protein immunosuppression method were
observed and compared 24 h after the cells were treated with 4
different treatment methods. The change of expression level of
alpha-synuclein oligomers was shown more intuitively and
deeply. It was shown in the results that the expression level of
alpha-synuclein oligomers of the cells induced by lactacystin in
group L was signiﬁcantly higher than that of the control group
only treated with DMSO. And the expression level of alpha-
synuclein oligomers of the cells treated with lactacystin and
tubacin in group T+L after inhibiting HDAC-6 was signiﬁcantly
higher than group L. The difference of the expression level of
alpha-synuclein oligomers of the cells only treated with tubacin
in group T and the control group of DMSO was not statistically
signiﬁcant. The results indicate that the inhibition of HDAC-6
can promote the formation of alpha-synuclein oligomers in the
PD cells, suggesting that HDAC-6 may have an effect of
inhibiting the formation of alpha-synuclein oligomers on the PD
cell model induced by lactacystin.
As an important member of low molecular weight heat shock
protein family, heat shock protein 27 (HSP 27) is an important
protein involved in the function of cell growth, apoptosis, drug
resistance, occurrence and metastasis of tumor and so on, which
may be related to its inﬂuence on other proteins [24]. When a cell
is not stressed, the expression level of HSP-27 is low and it is
mainly large polymer without activity generally. While a cell is
stressed, the expression level of HSP-27 will increase signiﬁ-
cantly and HSP-27 is activated with phosphorylation to perform
its speciﬁc function [25–27]. HSP-70 is also a very important
member of heat shock protein family, including 20 kinds of
proteins with molecular weight of 68, 72, 73, 75, 78 kDa and so
on [28]. HSP-70 with molecular weight of 70 kDa (induction
type) is the most one studied in heat shock protein, whose
expression level is low in normal cells but signiﬁcantly increases
under stress. In particular, structure, function and expressionregulation mechanism of HSP-70 family are studied a lot. Under
normal condition, HSP-70 is in the cytoplasm. When stimulated
by heat shock, HSP-70 increases rapidly in the nucleus and there
are only a few in the cytoplasm. In the recovery phase of cells,
the HSP-70 in the nucleus disappears and there is still a low
expression level of HSP-70 in the cytoplasm [29]. Normally,
HSP-70 shows a basic expression in the cell and the expres-
sion level is low. In the case of high temperature and all kinds of
harmful stress or abnormal genes, the synthesis rate of HSP-70
signiﬁcantly increases, which can reach the highest level
within a few minutes generally, while the original protein syn-
thesis is reduced, in order to improve the anti-stress ability of
organism [30].
In the study, the expression level of HSP-27 and HSP-70
detected by protein immunosuppression method were observed
and compared 24 h after the cells were treated with 4 different
treatment methods. It was shown in the results that the expres-
sion level of HSP-27 and HSP-70 of the cells of group L were
signiﬁcantly higher than that of the control group. And the
expression level of HSP-27 and HSP-70 of the cells of group
T+L were lower than group L. The difference of the expression
level of HSP-27 and HSP-70 of the cells of group T and the
control group of DMSO was not statistically signiﬁcant. The
results indicate that after inhibiting HDAC-6, PD cell model can
reduce the expression level of HSP-27 and HSP-70 to reduce the
repair and removal of abnormal proteins, so that the formation of
alpha-synuclein oligomers in the PD cells can be promoted,
suggesting that HDAC-6 can inhibit the formation of alpha-
synuclein oligomers in the PD cell model induced by lactacys-
tin by increasing the expression level of HSP-27 and HSP-70.
At the same time, it can be found in this study that the cell
survival rate can be sorted from high to low as the control group,
group L and group T+L. There was no signiﬁcant difference
between the cell survival rate of group T and the control group
after cell treatment. It can be indicated that the inhibition of
HDAC-6 can serve to damage cell structure and function, which
may be associated with the damage of mitochondria and
phagocytic structure in the cell, suggesting that HDAC-6 may
play a role on the protection of the PD cell model induced by
lactacystin.
In summary, HDAC-6 may improve the expression level of
HSP-27 and HSP-70 to inhibit the formation of alpha-synuclein
oligomers in the PD cells, which plays a role in protecting cells.
Bur it remains to be conﬁrmed that whether the clinical symp-
toms of PD patients can be controlled by means of increasing the
expression level of HSP-27 and HSP-70 to more inhibit the
aggregation and folding of alpha-synuclein oligomers in the PD
cells and whether it can be applied to the clinic.Conﬂict of interest statement
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